RankAlpha logo
Back to Rankings

CNTX

Context TherapeuticsA
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
The $0.2393 October 23 anchor and roughly $22 million supplied market capitalization sit below the $43 million cash balance reported at June 30. Successful CTIM-76 data or CT-202 early activity could narrow that discount, but cash is being spent on development [#PR-EARNINGS-2026-08-05].
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite.
What can break
CT-95 discontinuation concentrates development risk in CTIM-76 and CT-202 [#PR-EARNINGS-2026-08-05].
Momentum
99
Value
58
Sentiment
70
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $0.25 · Bull $0.40 · Bear $0.10Analysis 2026-10-25; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-28 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-25 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-28

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-28. Definitions

Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $4.13
Why
Momentum99 · Δ7d -
Value58 · Δ7d -0.1
Sentiment70 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Sentiment remains the lead driver in the composite.

Contradictions & invalidation

  • • CT-95 discontinuation concentrates development risk in CTIM-76 and CT-202 [#PR-EARNINGS-2026-08-05].
  • • Cash declined from $66 million at year-end 2025 to $43 million at June 30, 2026; the company's runway estimate into Q4 2027 depends on spending assumptions [#PR-EARNINGS-2026-08-05].
  • • Early interim efficacy may fail to replicate in larger or differently dosed groups.

Catalyst clock

2026-12-31

CTIM-76 every-three-week dosing execution

Lead driver: Sentiment · See AI snapshot
Momentum
99
8% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
58
47% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.5
Sentiment
70
45% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade

Composite grade A. Momentum 99.1 / Value 57.5 / Sentiment 70.0

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-25. Scenario method

B+
Bull case
20%
Probability
Target price
$0.40
Analysis reference price unavailable
Analysis 2026-10-25 · RankAlpha Sentiment Codex
Most likely
B
Base case
45%
Probability
Target price
$0.25
Analysis reference price unavailable
Analysis 2026-10-25 · RankAlpha Sentiment Codex
B-
Bear case
35%
Probability
Target price
$0.10
Analysis reference price unavailable
Analysis 2026-10-25 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$21.56M
Beta
1.91
Shares Out
91.88M
P/E (TTM) · Derived
-0.6
P/S (TTM)
-
P/FCF (TTM) · Derived
-0.65
Rev YoY
-
EPS YoY
+65.0%
Gross Margin
-
Op Margin
-
Net Debt
-$65.88M
Current Ratio
5.79
As of 2026-10-28 • Updated nightlySource: Internal modelMethods & Data